Skip to main content
. 2020 Mar 31;27(1):502–518. doi: 10.1080/10717544.2020.1745328

Figure 7.

Figure 7.

Therapeutic effect of RSV-loaded novel biomimetic nanosystems in vitro. FCM analysis of (A) mitochondrial ROS accumulation obtained by MitoSOX and (B) intracellular H2O2 level by CM-H2DCFDA in Aβ23–35-damaged HT22 cells after treatment with different RSV-loaded formulations. Changes of (C) MnSOD and (D) MDA levels in Aβ23–35-damaged HT22 cells after treatment with different RSV-loaded formulations. (E) Apoptosis results of Aβ23–35-damaged HT22 cells after treatment with different RSV-loaded formulations. The data are presented as the means ± SD (n = 3). * indicates p < 0.05.